High-dose methotrexate and Adriamycin in osteogenic sarcoma
PCNU
Multiple myeloma
Hexamethylmelamine and prednisone in the treatment of refractory multiple myeloma
Phase II evaluation of 4'-(9-acridinylamino)-methanesulfon-m-anisidine (AMSA) in patients with advanced head and neck cancers
Dibromodulcitol and Adriamycin ± tamoxifen in advanced breast cancer*
Vindesine in bronchogenic carcinoma
Phase II trial of VP-16-213 in non-small-cell lung cancer
A phase II trial of vindesine in patients with refractory small-cell carcinoma of the lung
Current status of chemotherapy, hormonal therapy, and immunotherapy in the treatment of renal cell carcinoma
Phase II study of Baker's antifol (triazinate, TZT, NSC-139, 105) in advanced squamous cell carcinoma of cervix
Adjuvant immunotherapy (BCG) in Stage D prostate cancer
Phase II study of 3-deazauridine in advanced colorectal adenocarcinoma
Misonidazole enhancement of the action of BCNU and melphalan against human melanoma xenografts
Potentiation of radiation injury by interferon*
Second neoplasms following radiotherapy or chemotherapy for cancer